The abstract is read at the publisher; the summary is JClub's.
Emotional distress at ICI start is linked to impaired overall survival in melanoma patients receiving anti-PD-1 monotherapy in the metastatic setting, with HRadj 2.10.
- Why it matters: Prior work in neoadjuvant melanoma suggests emotional distress can harm ICI outcomes, but its prognostic value in metastatic and adjuvant settings is unclear.
- What they did: In 555 melanoma patients (2015–2025), emotional distress was measured at ICI initiation using the Utrecht Symptom Diary, and Cox regression adjusted for confounders tested associations with PFS, RFS, OS, and MSS.
- The result: Among 169 metastatic anti-PD-1 patients, ED was also linked to worse melanoma-specific survival (HRadj 2.24) and showed a non-significant PFS association (HRadj 1.56). In contrast, ED showed no survival associations with IPINIVO in 193 metastatic patients, and in 193 adjuvant anti-PD-1 patients ED was linked to worse RFS (HRadj 2.29) and OS (HRadj 2.35).
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.